Oligonucleotide Drug Product Characterization, Optimization & Development
Time: 11:30 am
day: Day Two AM
Details:
• Proactive approaches to establish effective control strategies in early-stage programs.
• Considerations regarding drug product formulations
• Regulatory considerations for drug product manufacturing for successful submission
and market approval
